S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

COLL Collegium Pharmaceutical Inc

32.91

-0.43 (-1.29%)

Jan 10 2025 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Collegium Pharmaceutical (NASDAQ:COLL)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Collegium Pharmaceutical Charts.

Collegium Pharmaceutical (NASDAQ:COLL)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Collegium Pharmaceutical Charts.

Collegium Pharmaceutical Inc News

Form 144 - Report of proposed sale of securities
Friday 10 January 2025 (20 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 8 January 2025 (3 days ago) • Edgar (US Regulatory)

Collegium Provides 2025 Financial Guidance and Business Update
Wednesday 8 January 2025 (3 days ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Collegium to Participate in Upcoming Investor Conferences
Tuesday 12 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Collegium Reports Record Third Quarter 2024 Financial Results
Thursday 7 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Collegium Appoints Vikram Karnani as Chief Executive Officer
Thursday 7 November 2024 (2 months ago) • GlobeNewswire Inc.

Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024
Thursday 24 October 2024 (3 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 September 2024 (4 months ago) • Edgar (US Regulatory)

More Collegium Pharmaceutical Inc News Articles

BNP Paribas Issuance

Societe Generale Effekten

Invesco S & P 500 High D...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions